Publications by authors named "Giulio Viceconte"

Claim this Profile
A
Activity of sotrovimab in early clearance of SARS CoV-2 infection in severe immunocompromised patients: results of a prospective, monocentric study.
Giulio Viceconte, Antonio Riccardo Buonomo, Emilia Trucillo, Alessia D'Agostino, Daria Pietroluongo

Infect Dis (Lond)· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of rapid and advanced microbiological methods in critical care: 2025 Emanuele Russo Delphi consensus.
Vittorio Sambri, Vanni Agnoletti, Simone Ambretti, Michele Bartoletti, Paola Bernaschi, Giulio Viceconte

Clin Microbiol Infect· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outbreak of Human Neuroinvasive West Nile Virus Infection in Campania, Italy, August-September 2024.
Nunzia Esposito, Giulio Viceconte, Lidia Festa, Francesco Antimo Alfè, Canio Carriero

Vector Borne Zoonotic Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caspofungin for Primary Antifungal Prophylaxis in Acute Myeloid Leukemia: A Real-Life Study from an Academic Center.
Francesco Grimaldi, Mara Memoli, Simona Avilia, Carlangela Causa, Maria Luisa Giannattasio, Giulio Viceconte

Cancers (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study).
Ivan Gentile, Agnese Giaccone, Maria Michela Scirocco, Francesco Di Brizzi, Federica Cuccurullo, Giulio Viceconte

BMC Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Safety and Effectiveness of Rezafungin Treatment in Candidemia and Invasive Candidiasis: Results From an Early Access Program in Italy and Germany.
Filippo Trapani, Giulio Viceconte, Valentina Morena, Giusy Tiseo, Giovanni Mori

Open Forum Infect Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Molnupiravir in Reducing the Risk of Severe Outcomes in Patients with SARS-CoV-2 Infection: A Real-Life Full-Matched Case-Control Study (SAVALO Study).
Ivan Gentile, Riccardo Scotto, Maria Michela Scirocco, Francesco Di Brizzi, Federica Cuccurullo, Giulio Viceconte

Microorganisms· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxoplasma Gondii Replication During Belatacept Treatment in Kidney Transplantation: A Case Report and a Review of the Literature.
Raffaella Vigilante, Raafiah Izhar, Rossella Di Paola, Ananya De, Rosa Maria Pollastro, Giulio Viceconte

Genes (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study).
Ivan Gentile, Agnese Giaccone, Maria Michela Scirocco, Francesco Di Brizzi, Federica Cuccurullo, Giulio Viceconte

BMC Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Carbapenem-Resistant in Real Life (T-ACI): A Prospective Single-Center Observational Study.
Antonio Riccardo Buonomo, Riccardo Scotto, Nunzia Esposito, Giulio Viceconte, Nicola Schiano Moriello

Antibiotics (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study.
Erica Pietroluongo, Annarita Peddio, Pietro De Placido, Marianna Tortora, Margaret Ottaviano, Giulio Viceconte

BMC Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019.
Buonomo A Riccardo, Saccone Gabriele, Esposito Nunzia, Di Filippo Isabella, Pinchera Biagio, Viceconte Giulio

Am J Perinatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage Therapy with Rezafungin for Spondylodiscitis: A Case Report from Expanded Access Program.
Giulio Viceconte, Antonio Riccardo Buonomo, Nunzia Esposito, Letizia Cattaneo, Teresa Somma

Microorganisms· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient Use of Monoclonal Antibodies Casirivimab and Imdevimab in Pregnancy for Mild-to-Moderate Coronavirus Disease 2019.
Antonio Riccardo Buonomo, Isabella Di Filippo, Nunzia Esposito, Gabriele Saccone, Mariano Nobile, Giulio Viceconte

Am J Perinatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab.
Ivan Gentile, Maria Foggia, Maria Silvitelli, Alessia Sardanelli, Letizia Cattaneo, Giulio Viceconte

Virol J· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Colonization in Non-Critical Immunocompetent COVID-19 Patients: A Single-Center Prospective Study (JiroCOVID Study).
Antonio Riccardo Buonomo, Giulio Viceconte, Ludovica Fusco, Marina Sarno, Isabella di Filippo

Microorganisms· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study.
Giulio Viceconte, Antonio Riccardo Buonomo, Alessia D'Agostino, Maria Foggia, Antonio Di Fusco

J Fungi (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of oral antiviral therapy against HCV on gut microbiota. A prospective study.
Biagio Pinchera, Riccardo Scotto, Emanuela Zappulo, Antonio Riccardo Buonomo, Alberto Enrico Maraolo, Giulio Viceconte

New Microbiol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbiota and hepatitis C virus in the era of direct-acting antiviral agents.
Biagio Pinchera, Nicola Schiano Moriello, Antonio Riccardo Buonomo, Emanuela Zappulo, Giulio Viceconte

Microb Pathog· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experience.
Nicola Schiano Moriello, Antonio Riccardo Buonomo, Riccardo Scotto, Biagio Pinchera, Marina Sarno, Giulio Viceconte

Heliyon· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital Health Service for Identification of Frailty Risk Factors in Community-Dwelling Older Adults: The SUNFRAIL+ Study Protocol.
Vincenzo De Luca, Grazia Daniela Femminella, Lisa Leonardini, Lola Patumi, Ernesto Palummeri, Giulio Viceconte

Int J Environ Res Public Health· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive Fungal Infections in Hospitalized Patients with COVID-19: A Non-Intensive Care Single-Centre Experience during the First Pandemic Waves.
Letizia Cattaneo, Antonio Riccardo Buonomo, Carmine Iacovazzo, Agnese Giaccone, Riccardo Scotto, Giulio Viceconte

J Fungi (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge: a single center case-control study.
Giulio Viceconte, Andrea Ponsiglione, Antonio Riccardo Buonomo, Luigi Camera, Riccardo Scotto

Infez Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19.
Riccardo Scotto, Amedeo Lanzardo, Antonio Riccardo Buonomo, Biagio Pinchera, Letizia Cattaneo, Giulio Viceconte

Vaccines (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy).
Ivan Gentile, Martina Iorio, Emanuela Zappulo, Riccardo Scotto, Alberto Enrico Maraolo, Giulio Viceconte

Int J Environ Res Public Health· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis